These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 12237785)

  • 1. Synthesis of research findings regarding the care of people with Alzheimer's disease--Part II.
    Bower FL; McCullough CS; Pille BL
    Online J Knowl Synth Nurs; 2002 Aug; 9():4. PubMed ID: 12237785
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alzheimer's disease. A psychiatrist's perspective.
    Billig N
    Nurs Clin North Am; 1988 Mar; 23(1):125-33. PubMed ID: 3347573
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Non pharmacological interventions in dementia: a review and prospect].
    Dorenlot P
    Psychol Neuropsychiatr Vieil; 2006 Jun; 4(2):135-44. PubMed ID: 16753587
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nonpharmacological and pharmacological interventions for symptoms in Alzheimer's disease.
    Overshott R; Byrne J; Burns A
    Expert Rev Neurother; 2004 Sep; 4(5):809-21. PubMed ID: 15853508
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis of research findings regarding Alzheimer's disease: part III, Caregiver burden and care settings.
    Bower FL; McCullough CS; Pille BL
    Online J Knowl Synth Nurs; 2002 Oct; 9():5. PubMed ID: 12439757
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Behavioral disturbances in Alzheimer's disease: a non-pharmacological therapeutic approach.
    Silvestri A; Rosano G; Zannino G; Ricca F; Marigliano V; Fini M
    Arch Gerontol Geriatr Suppl; 2004; (9):379-86. PubMed ID: 15207436
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methodological concerns: evaluating central nervous system (CNS) active compounds in Alzheimer's disease (AD).
    Cutler NR
    Prog Clin Biol Res; 1989; 317():1311-7. PubMed ID: 2602412
    [No Abstract]   [Full Text] [Related]  

  • 8. Alzheimer's disease.
    Pendlebury WW; Solomon PR
    Clin Symp; 1996; 48(3):2-32. PubMed ID: 8961620
    [No Abstract]   [Full Text] [Related]  

  • 9. [Impact of music therapy on anxiety and depression for patients with Alzheimer's disease and on the burden felt by the main caregiver (feasibility study)].
    Guetin S; Portet F; Picot MC; Defez C; Pose C; Blayac JP; Touchon J
    Encephale; 2009 Feb; 35(1):57-65. PubMed ID: 19250995
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Humour therapy in patients with late-life depression or Alzheimer's disease: a pilot study.
    Walter M; Hänni B; Haug M; Amrhein I; Krebs-Roubicek E; Müller-Spahn F; Savaskan E
    Int J Geriatr Psychiatry; 2007 Jan; 22(1):77-83. PubMed ID: 16977676
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recommendations for best practices in the treatment of Alzheimer's disease in managed care.
    Fillit HM; Doody RS; Binaso K; Crooks GM; Ferris SH; Farlow MR; Leifer B; Mills C; Minkoff N; Orland B; Reichman WE; Salloway S
    Am J Geriatr Pharmacother; 2006; 4 Suppl A():S9-S24; quiz S25-S28. PubMed ID: 17157793
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risperidone use in Korean patients with Alzheimer's disease: optimal dosage and effect on behavioural and psychological symptoms, cognitive function and activities of daily living.
    Yoon JS; Kim JM; Lee H; Shin IS; Choi SK
    Hum Psychopharmacol; 2003 Dec; 18(8):627-33. PubMed ID: 14696022
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Predictors of long-term institutionalization in patients with Alzheimer's disease: role of caregiver burden].
    Hirono N; Tsukamoto N; Inoue M; Moriwaki Y; Mori E
    No To Shinkei; 2002 Sep; 54(9):812-8. PubMed ID: 12428367
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of Alzheimer's disease: the role of symptomatic agents in an era of disease-modifying therapies.
    Cummings JL
    Rev Neurol Dis; 2007; 4(2):57-62. PubMed ID: 17609636
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A 2-year open-label study of galantamine therapy in Chinese Alzheimer's disease patients in Hong Kong.
    Chu LW; Yik PY; Mok W; Chung CP
    Int J Clin Pract; 2007 Mar; 61(3):403-10. PubMed ID: 17313606
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Research on Alzheimer's caregiving in Canada: current status and future directions.
    Chambers LW; Hendriks A; Hall HL; Raina P; McDowell I;
    Chronic Dis Can; 2004; 25(3-4):108-18. PubMed ID: 15844250
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Utilizing combination therapy in the treatment of Alzheimer's disease.
    Farlow MR
    Expert Rev Neurother; 2004 Sep; 4(5):799-808. PubMed ID: 15853507
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contemporary issues in the treatment of Alzheimer's disease: tangible benefits of current therapies.
    Tariot PN
    J Clin Psychiatry; 2006; 67 Suppl 3():15-22; quiz 23. PubMed ID: 16649847
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Everyday technologies for Alzheimer's disease care: Research findings, directions, and challenges.
    Carrillo MC; Dishman E; Plowman T
    Alzheimers Dement; 2009 Nov; 5(6):479-88. PubMed ID: 19896587
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost-effectiveness of memantine for moderate to severe Alzheimer's disease in Sweden.
    Jönsson L
    Am J Geriatr Pharmacother; 2005 Jun; 3(2):77-86. PubMed ID: 16129384
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.